Abstract
Introduction
Total knee arthroplasty (TKA) is a proven treatment method for advanced knee arthritis in terms of pain relief, function restoration, and quality-of-life improvement. The TKA use has increased significantly over the past decade and the growing rate is more prominent in Asian countries. Thus, the revision TKA may also increase in recent days, which represents a burden to the national health care system. To the best of our knowledge, little information is currently available regarding the incidence and related factors of revision TKA in Asian countries on the basis of nationwide database. This study sought to find the incidence of revision TKA and related factors in South Korea using national database from 2007 to 2012.
Material and Method
Data collected by the Health Insurance Review Agency of Korea, from 260,068 TKA patients between 2007 and 2012, were used to estimate the incidence of revision TKA according to age group, gender and hospital TKA and manufacturer prosthesis volume (i.e., the number of TKA procedures carried out at a given hospital, and the number of procedures performed using a given manufacturer's prosthesis, respectively). Age group and hospital and manufacturer volumes were categorized into three groups and TKA incidence rates were computed for groups stratified according to age, gender and hospital and manufacturer volumes.
Result
Incidence rates per 100,000 person-years were as follows: 1) by age: < 65 years, 447.2; 65–74 years, 363.7; ≥ 75 years, 270.9, 2) by gender: male, 537.8; female, 346.1; 3) by hospital volume (procedures/year): < 20, 536.9; 20–199, 432.3; ≥ 200, 300.1; and 4) by manufacturer volume (prostheses/year): < 1500, 772.3; 1500–3999, 453.9; ≥ 4000, 345.6. TKA incidence rate in young males was significantly higher compared to that in elderly females. The difference in cumulative incidence, between hospitals with an annual volume of < 20 procedures and those with a volume of 20–199 procedures, was reduced for manufacturers with an annual volume of ≥ 4000. Similarly, the difference in cumulative incidence between manufacturers with an annual volume of < 1500 and those with a volume of 1500–3999 was reduced in hospitals with an annual volume of ≥ 200.
Conclusions
Revision TKA incidence varied according to age, gender and hospital and manufacturer volumes. This data could inform clinical decisions and healthcare strategies.
